Infection prevention and control in cystic fibrosis: One size fits all The argument against

Alan R Smyth; Sherie J Smith; Nicola J Rowbotham

doi:10.1016/j.prrv.2019.08.001

Infection prevention and control in cystic fibrosis: One size fits all The argument against

Paediatr Respir Rev. 2020 Nov:36:94-96. doi: 10.1016/j.prrv.2019.08.001. Epub 2019 Aug 21.

Authors

Alan R Smyth¹, Sherie J Smith², Nicola J Rowbotham²

Affiliations

¹ School of Medicine, University of Nottingham, Nottingham, UK; Nottingham Evidence Based Child Health Group, School of Medicine, University of Nottingham, Nottingham, UK; Nottingham Children's Hospital, Nottingham, UK. Electronic address: alan.smyth@nottingham.ac.uk.
² School of Medicine, University of Nottingham, Nottingham, UK; Nottingham Evidence Based Child Health Group, School of Medicine, University of Nottingham, Nottingham, UK.

PMID: 31629644
DOI: 10.1016/j.prrv.2019.08.001

Abstract

As awareness of the risks of cross infection has increased, infection prevention and control measures have become more draconian. Infection control measures can have a profound effect of the organisation and delivery of CF services and on the lives of people with CF outside the hospital. However, the consequences of inadequate infection control measures may be the permanent acquisition of a chronic infection which is virtually untreatable. Recommendations for infection prevention and control therefore must protect patients but should also be evidence-based and proportionate. This article will review the literature, juxtaposing evidence and popular practise.

Keywords: Cystic fibrosis; Evidence; Infection prevention; Practise.

Publication types

Review

MeSH terms

Administration, Inhalation
Administration, Intravenous
Air Filters
Anti-Bacterial Agents / therapeutic use
Burkholderia Infections / drug therapy
Burkholderia Infections / prevention & control
Cross Infection / prevention & control*
Cystic Fibrosis / microbiology
Cystic Fibrosis / therapy*
Disease Management
Drug Resistance, Bacterial
Drug Resistance, Multiple, Bacterial
Evidence-Based Practice
Hand Hygiene
Humans
Infection Control / methods*
Masks
Methicillin-Resistant Staphylococcus aureus
Mycobacterium Infections, Nontuberculous / drug therapy
Mycobacterium Infections, Nontuberculous / prevention & control
Patient Isolation
Personal Protective Equipment
Physical Distancing
Practice Guidelines as Topic
Pseudomonas Infections / drug therapy
Pseudomonas Infections / prevention & control
Pseudomonas aeruginosa
Respiratory Tract Infections / drug therapy
Respiratory Tract Infections / prevention & control*
Spirometry
Staphylococcal Infections / drug therapy
Staphylococcal Infections / prevention & control
Ventilation

Substances

Anti-Bacterial Agents